Search - tctmd.com

Displaying 941 - 960 of 1934

Sort: Relevancy | Date

Presentation TCT 2017

REVASC: A Randomized Trial to Assess Recovery of Left Ventricular Function After PCI of Coronary Artery Chronic Total Occlusions

Presenter: Robert-Jan van Geuns, Kambis Mashayekhi

October 31, 2017

Presentation TCT 2017

TCT 99: Safety and Efficacy of Percutaneous Axillary Artery Access for Mechanical Circulatory Support With the Impella© Devices: An Initial Evaluation From the Axillary Access Registry to Monitor Safety (ARMS) MultiCenter Registry

Presenter: Vladimir Dzavik, Srihari S. Naidu, James M. McCabe

October 31, 2017

Presentation TCT 2017

TCT 43: Bioresorbable Scaffold for the Treatment of Calcified Coronary Lesions: IVUS Insights From the ABSORB Japan Trial

Presenter: Ulf Landmesser, Bernhard Witzenbichler, Kozo Okada, MD

October 31, 2017

Presentation TCT 2017

TCT 59: Prevalence, Predictors, and Outcomes of Bleeding Complications in Peripheral Vascular Interventions for Lower Extremities: Insights From the NCDR PVI Registry

Presenter: Sahil A. Parikh, Bhaskar Bhardwaj, MD

October 31, 2017

Presentation TCT 2017

TCT 36: Cerebral Embolic Protection During Transfemoral Aortic Valve Replacement Reduces Death and Stroke Compared to Unprotected Procedure in All Subgroups

Presenter: Reginald I. Low, Michael J. Rinaldi, Julia Seeger

October 31, 2017

Presentation TCT 2017

TCT 27: What is the Most Effective Treatment After Rotational Atherectomy for Stent Underexpansion?: An Inverse Probability of Treatment Weighting Analysis Based on Propensity Score

Presenter: Ehrin J. Armstrong, Gert Richardt, Daisuke Hahcinohe, MD

October 31, 2017

Presentation TCT 2017

TCT 9: Absorb Bioresorbable Vascular Scaffold vs Everolimus-Eluting Metallic Stent in Small Vessel Disease -A Propensity Matched Analysis of COMPARE II, RAI, and MAASSTAD-ABSORB Prospective Studies

Presenter: Yoshinobu Onuma, Joanna J. Wykrzykowska, Alberto Barioli, MD

October 31, 2017

Presentation TCT 2017

TCT 91: Antithrombotic Therapy Post Transcatheter Aortic Valve Replacement in Patients With No Indication for Anticoagulation

Presenter: Kurt Huber, Jamil Abdalla Saad, Dimitrios Alexopoulos, Antonio L. Bartorelli, Bjorn Redfors, Carlos E. Uribe

October 31, 2017

Presentation TCT 2017

TCT 3: Outcomes of Left Main Revascularization in Patients With Acute Coronary Syndrome vs Stable Angina: Analysis From the EXCEL Trial

Presenter: Rajesh M. Dave, A. Michael Lincoff, Marc Etienne Jolicoeur

October 31, 2017

Presentation TCT 2017

TCT 88: Catheter-Based Tricuspid Valve Replacement Via Right Atrium: An Animal Experimental Study

Presenter: Joachim Schofer, Ralph Stephan von Bardeleben, Peng Cao, MD

October 31, 2017

Presentation TCT 2017

TCT 75: Impact of the Timing of P2Y12 Inhibitor Discontinuation Prior to CABG in Patients With Left Main Disease: Results from the EXCEL Trial

Presenter: Adrian P. Banning, John D. Puskas, Christopher Kelly, MD

October 31, 2017

Presentation TCT 2017

TCT 67: Clinical Relevance of Functionally Insignificant Moderate Coronary Artery Stenosis Assessed by 3-vessel Fractional Flow Reserve Measurement

Presenter: Allen Jeremias, Amir Lerman, Jonghanne Park, MD

October 31, 2017

Presentation TCT 2017

TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials

Presenter: Peter C. Block, Lars Sondergaard, Tarun Chakravarty, MD

October 31, 2017

Presentation TCT 2017

DEBATE-SFA: A Randomized Trial of a BMS With or Without Cilostazol vs a DES in Patients With Femoropopliteal Disease

Presenter: David P. Faxon, Joseph A. Hill, Yusuke Miyashita

October 31, 2017

Presentation TCT 2017

Pelvic Congestion Syndrome: Management and Developing an Office-Based Practice

Presenter: Brian G. DeRubertis, Bret N. Wiechmann

October 31, 2017

Presentation TCT 2017

CrossBoss First: A Randomized Trial of Antegrade Dissection and Re-entry vs Standard Wire Escalation for Crossing Coronary Artery Chronic Total Occlusions

Presenter: Robert-Jan van Geuns, Emmanouil S. Brilakis

October 31, 2017

Presentation TCT 2017

TCT 58: Biomechanics and Drug Elution in Arterial Response to Peripheral Stents: A Comparative Study of 3 Contemporary Stents in Balloon-Predilated Femoral Arteries of Familial Hypercholesterolemic Swine

Presenter: Sahil A. Parikh, Yanping Cheng, MD

October 31, 2017

Presentation TCT 2017

TCT 42: LONG-TERM CONSEQUENCES of Optical coherence tomography FINDINGS DURING PERCUTANEOUS CORONARY INTERVENTION: The Centro per la Lotta contro lInfarto - Optimization of Percutaneous Coronary Intervention (CLI-OPCI) LATE Study

Presenter: Ulf Landmesser, Bernhard Witzenbichler, Enrico Romagnoli, MD

October 31, 2017

Presentation TCT 2017

TCT 98: Percutaneous Right Ventricular Support With Impella RP in Severe Right Ventricular Failure: Insights From Impella RP Clinical Studies.

Presenter: Vladimir Dzavik, Srihari S. Naidu, Mark B. Anderson

October 31, 2017

Presentation TCT 2017

TCT 34: Prediction of Acute Kidney Injury After TAVR by New Biomarkers

Presenter: Reginald I. Low, Michael J. Rinaldi, Mani Arsalan, MD

October 31, 2017

Advertisement

REVASC: A Randomized Trial to Assess Recovery of Left Ventricular Function After PCI of Coronary Artery Chronic Total Occlusions

TCT 99: Safety and Efficacy of Percutaneous Axillary Artery Access for Mechanical Circulatory Support With the Impella© Devices: An Initial Evaluation From the Axillary Access Registry to Monitor Safety (ARMS) MultiCenter Registry

TCT 43: Bioresorbable Scaffold for the Treatment of Calcified Coronary Lesions: IVUS Insights From the ABSORB Japan Trial

TCT 59: Prevalence, Predictors, and Outcomes of Bleeding Complications in Peripheral Vascular Interventions for Lower Extremities: Insights From the NCDR PVI Registry

TCT 36: Cerebral Embolic Protection During Transfemoral Aortic Valve Replacement Reduces Death and Stroke Compared to Unprotected Procedure in All Subgroups

TCT 27: What is the Most Effective Treatment After Rotational Atherectomy for Stent Underexpansion?: An Inverse Probability of Treatment Weighting Analysis Based on Propensity Score

TCT 9: Absorb Bioresorbable Vascular Scaffold vs Everolimus-Eluting Metallic Stent in Small Vessel Disease -A Propensity Matched Analysis of COMPARE II, RAI, and MAASSTAD-ABSORB Prospective Studies

TCT 91: Antithrombotic Therapy Post Transcatheter Aortic Valve Replacement in Patients With No Indication for Anticoagulation

TCT 3: Outcomes of Left Main Revascularization in Patients With Acute Coronary Syndrome vs Stable Angina: Analysis From the EXCEL Trial

TCT 88: Catheter-Based Tricuspid Valve Replacement Via Right Atrium: An Animal Experimental Study

TCT 75: Impact of the Timing of P2Y12 Inhibitor Discontinuation Prior to CABG in Patients With Left Main Disease: Results from the EXCEL Trial

TCT 67: Clinical Relevance of Functionally Insignificant Moderate Coronary Artery Stenosis Assessed by 3-vessel Fractional Flow Reserve Measurement

TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials

DEBATE-SFA: A Randomized Trial of a BMS With or Without Cilostazol vs a DES in Patients With Femoropopliteal Disease

Pelvic Congestion Syndrome: Management and Developing an Office-Based Practice

CrossBoss First: A Randomized Trial of Antegrade Dissection and Re-entry vs Standard Wire Escalation for Crossing Coronary Artery Chronic Total Occlusions

TCT 58: Biomechanics and Drug Elution in Arterial Response to Peripheral Stents: A Comparative Study of 3 Contemporary Stents in Balloon-Predilated Femoral Arteries of Familial Hypercholesterolemic Swine

TCT 42: LONG-TERM CONSEQUENCES of Optical coherence tomography FINDINGS DURING PERCUTANEOUS CORONARY INTERVENTION: The Centro per la Lotta contro lInfarto - Optimization of Percutaneous Coronary Intervention (CLI-OPCI) LATE Study

TCT 98: Percutaneous Right Ventricular Support With Impella RP in Severe Right Ventricular Failure: Insights From Impella RP Clinical Studies.

TCT 34: Prediction of Acute Kidney Injury After TAVR by New Biomarkers

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content